Add like
Add dislike
Add to saved papers

Removal of inert COD and trace metals from stabilized landfill leachate by granular activated carbon (GAC) adsorption.

Landfills in Germany are currently approaching stabilization phase; as a result removal of inert organics and potentially toxic elements in the leachate is becoming a primary concern. Dissolved air floatation (DAF) at the secondary stage reduces only 27% of the residual chemical oxygen demand (COD) in the investigated treatment systems; downstream granular activated carbon (GAC) units are required to further reduce COD concentration by 40-56% to meet indirect discharge or direct discharge limits respectively. Therefore, in this study performance in terms of COD and trace metals adsorption of different types of granular activated carbon were compared over different contact times and dosages. GAC 1 with Brunauer-Emmett-Teller (BET) surface area of 719.5 ± 2.1 m2 /g and average pore diameter (D) of 4.81 nm was identified to be inappropriate for treatment of leachate from this landfill. GAC 2 (with BET of 1513.7 ± 6.4 m2 /g and D of 3.50 nm) was feasible for COD reduction from DAF-pretreated leachate, while GAC 3 (with BET of 644.5 ± 2.6 m2 /g and D of 5.65 nm) can be coupled either with biological step alone, or as a tertiary step after the DAF unit. Moreover, as COD is the primary remaining contaminant of interest after secondary and tertiary treatment, spectrometer probes provide a close estimation of COD concentration for use in online monitoring. Beside COD removal, GAC 3 also confirmed the effectiveness of trace metals adsorption even at trace level, as it removed 66, 64, 48, 47, 43, and 25% of copper, cobalt, chromium, manganese, nickel, and zinc, respectively.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app